Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 13/20 | 1.00 |
| ▸ | HTR2B | P41595 | 9/20 | 1.00 |
| ▸ | HTR2A | P28223 | 13/20 | 0.72 |
| ▸ | HTR1A | P08908 | 1/20 | 0.59 |
| ▸ | HTR6 | P50406 | 4/20 | 0.47 |
| ▸ | HTR1D | P28221 | 1/20 | 0.41 |
| ▸ | INPPL1 | O15357 | 1/20 | 0.38 |
| ▸ | INPP5B | P32019 | 1/20 | 0.38 |
| ▸ | INPP5A | Q14642 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29405683 | 1.00 | HTR2C (1.00) | HTR2CHTR2BHTR2AHTR1AHTR6 | |
| SCHEMBL29361303 | 0.85 | HTR2C (0.75) | HTR2CHTR2BHTR2AHTR1AHTR6 | |
| SCHEMBL23723408 | 0.85 | HTR2C (0.75) | HTR2CHTR2BHTR2AHTR1AHTR6 | |
| SCHEMBL23747012 | 0.84 | HTR2C (1.00) | HTR2CHTR2BHTR2AHTR1AHTR6 | |
| SCHEMBL25074655 | 0.82 | HTR2C (0.69) | HTR2CHTR2BHTR2AHTR1AHTR6 | |
| SCHEMBL12558826 | 0.82 | HTR2C (0.69) | HTR2CHTR2BHTR2AHTR1AHTR6 | |
| SCHEMBL26096979 | 0.81 | HTR2C (0.67) | HTR2CHTR2BHTR2AHTR6HTR1D | |
| SCHEMBL23805247 | 0.79 | HTR2C (0.65) | HTR2CHTR2BHTR2AHTR6HTR1D | |
| SCHEMBL3177004 | 0.79 | HTR2C (0.65) | HTR2CHTR2BHTR2AHTR1AHTR6 | |
| SCHEMBL30681655 | 0.79 | HTR2C (0.65) | HTR2CHTR2BHTR2AHTR1AHTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023044556-A1 | AMINATED PSILOCYBIN DERIVATIVES AND METHODS OF USING | Enveric Biosciences Canada Inc. (CA) | 2023-03-30 | — | — | WO | disclosed |